Safety, Efficacy and Tolerability in the treatment of patients with Chronic Hepatitis C and Severe Renal Impairment

被引：0

作者：

Czul, Frank ^{[1
]}

Peyton, Adam ^{[1
]}

O'Brien, Christopher ^{[1
]}

Jeffers, Lennox J. ^{[1
]}

Martin, Paul ^{[1
]}

Bhamidimarri, Kalyan R. ^{[1
]}

机构：

[1] Univ Miami, Hepatol, Miami, FL USA

来源：

HEPATOLOGY | 2015年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2256

引用

页码：1305A / 1306A

页数：3

共 50 条

[31] Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis
Ahn, Sang Bong
Jun, Dae Won
Kim, Sang Gyune
Lee, Sae Hwan
Shin, Hyun Phil
Choe, Won Hyeok
Kim, Ja Kyung
Jung, Kyu Sik
Kim, Do Young
Shim, Jae-Jun
Park, Soo Young
Seo, Yeon Seok
Kim, Won
Chung, Jae Il
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2015, 26 (04) : 292 - 296
[32] The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort
Yaras, Serkan
Demir, Mehmet
Barutcu, Sezgin
Yildirim, Abdullah Emre
Gurel, Selim
Ucbilek, Enver
Kurtulmus, Ilkce Akgun
Kayhan, Meral Akdogan
Vatansever, Sezgin
Adanir, Haydar
Danis, Nilay
Duman, Serkan
Turan, Ilker
Ari, Derya
Kose, Sukran
Alkim, Huseyin
Harputluoglu, Muhsin Murat
Dilber, Feyza
Akyildiz, Murat
Cosar, Arif Mansur
Durak, Serdar
Sirin, Goktug
Kefeli, Ayse
Gokcan, Hale
Avcioglu, Ufuk
Ayyildiz, Talat
Sezgin, Orhan
Akarsu, Mesut
Dincer, Dinc
Guzelbulut, Fatih
Gunsar, Fulya
Akarca, Ulus Salih
Idilman, Ramazan
HEPATOLOGY FORUM, 2023, 4 (03): : 92 - 96
[33] Reply to: Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C
Sakin, Yusuf Serdar
Polat, Zulfikar
Demirci, Hakan
Kekilli, Murat
Uygun, Ahmet
Bagci, Sait
HEPATOLOGY RESEARCH, 2014, 44 (09) : 1037 - 1037
[34] Efficacy, tolerability and safety of mirtazapine in the treatment of patients with moderate or severe major depression
Iglesias, G
Mendoza, A
Ortega, M
Flores, J
Borges, HL
García, J
Martínez, D
Márquez, G
Iacobelli, M
Pavón, L
JOURNAL OF AFFECTIVE DISORDERS, 2004, 78 : S118 - S118
[35] Safety and Efficacy of Linagliptin in Type 2 Diabetes Patients with Severe Renal Impairment
Sloan, Lance
Newman, Jennifer
Sauce, Christophe
Von Eynatten, Maximilian
Patel, Sanjay
Woerle, Hans J.
DIABETES, 2011, 60 : A114 - A114
[36] Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment
Cherney, David Z. I.
Ferrannini, Ele
Umpierrez, Guillermo E.
Peters, Anne L.
Rosenstock, Julio
Carroll, Amy K.
Lapuerta, Pablo
Banks, Phillip
Agarwal, Rajiv
DIABETES OBESITY & METABOLISM, 2021, 23 (12): : 2632 - 2642
[37] The safety and efficacy of Linagliptin in patients with type 2 diabetes with severe renal impairment
Sloan, L.
Newman, J.
Sauce, C.
von Eynatten, M.
Patel, S.
Woerle, H. J.
Katsadze, V.
DIABETES & METABOLISM, 2012, 38 : A102 - A103
[38] Evaluation of the Safety and Efficacy of Denosumab in Patients With Multiple Myeloma and Severe Renal Impairment
Terpos, Evangelos
Ntanasis-Stathopoulos, Ioannis
Kyriakou, Charalampia
Tan, Carlyn
Abildgaard, Niels
Delforge, Michel
Fantl, Dorotea
Usmani, Saad
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S198 - S199
[39] Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection and Moderate to Severe Renal Impairment: An Integrated Analysis
Lawitz, Eric J.
Gane, Edward J.
Zadeikis, Neddie
Sise, Meghan
Zamor, Philippe J.
Persico, Marcell
Yoshida, Eric M.
Abunimeh, Manal
Pugatch, David
Yu, Yao
Krishnan, Preethi
Mensa, Federico J.
Pol, Stanislas
HEPATOLOGY, 2018, 68 : 426A - 426A
[40] Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
Manolakopoulos, Spilios
Zacharakis, George
Zissis, Miltiadis
Giannakopoulos, Vassilis
ANNALS OF GASTROENTEROLOGY, 2016, 29 (03): : 282 - 296

← 1 2 3 4 5 →